COVID-19 in underlying COPD Patients

Authors

  • Krishna Sunkara Intensive Care Unit, John Hunter Hospital, Newcastle, NSW, Australia. E-mail: krishnapriya.sunkara@gmail.com https://orcid.org/0000-0003-3412-0708
  • Venkata Allam Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden https://orcid.org/0000-0002-4330-5299
  • Shakti Shukla Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, NSW 2305, Australia https://orcid.org/0000-0002-5796-0171
  • Dinesh Kumar Chellappan Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia https://orcid.org/0000-0001-5567-6663
  • Gaurav Gupta School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India https://orcid.org/0000-0001-7941-0229
  • Ronan MacLoughlin Aerogen, IDA Business Park, Dangan, H91 HE94, Galway, Ireland; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland; School of Pharmacy and Pharmaceutical Sciences, Trinity College, D02 PN40 Dublin, Ireland https://orcid.org/0000-0002-3164-1607
  • Kamal Dua Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, NSW 2305, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney 2007, Australia https://orcid.org/0000-0002-7507-1159

DOI:

https://doi.org/10.17179/excli2021-3322

Keywords:

COPD, corticosteroids, COVID-19

Author Biographies

Dinesh Kumar Chellappan, Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia

https://orcid.org/0000-0001-5567-6663

Gaurav Gupta, School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India

https://orcid.org/0000-0001-7941-0229

Downloads

Published

2021-02-05

How to Cite

Sunkara, K., Allam , V. ., Shukla, S. ., Chellappan, D. K. ., Gupta, G. ., MacLoughlin, R. ., & Dua, K. (2021). COVID-19 in underlying COPD Patients. EXCLI Journal, 20, 248–251. https://doi.org/10.17179/excli2021-3322

Issue

Vol. 20 (2021)

Section

Letters to the editor

License

Copyright (c) 2021 Krishna Sunkara, Venkata Allam , Shakti Shukla, Dinesh Kumar Chellappan, Gaurav Gupta, Ronan MacLoughlin, Kamal Dua

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in this journal agree to the following terms:

  • The authors keep the copyright and grant the journal the right of first publication under the terms of the Creative Commons Attribution license, CC BY 4.0. This licencse permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.
  • The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
  • Because the advice and information in this journal are believed to be true and accurate at the time of publication, neither the authors, the editors, nor the publisher accept any legal responsibility for any errors or omissions presented in the publication. The publisher makes no guarantee, express or implied, with respect to the material contained herein.
  • The authors can enter into additional contracts for the non-exclusive distribution of the journal's published version by citing the initial publication in this journal (e.g. publishing in an institutional repository or in a book).

Most read articles by the same author(s)

<< < 1 2 3 > >>